760 related articles for article (PubMed ID: 28687594)
21. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
22. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM
J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222
[TBL] [Abstract][Full Text] [Related]
23. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR).
Jiang D; Xiao B; Yang D; Wang R; Choi P; Zhang L; Cheng H; Chen SR
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13062-7. PubMed ID: 15322274
[TBL] [Abstract][Full Text] [Related]
24. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
[TBL] [Abstract][Full Text] [Related]
25. Mutations in RYR1 in malignant hyperthermia and central core disease.
Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
[TBL] [Abstract][Full Text] [Related]
26. Role of Cys³⁶⁰² in the function and regulation of the cardiac ryanodine receptor.
Mi T; Xiao Z; Guo W; Tang Y; Hiess F; Xiao J; Wang Y; Zhang JZ; Zhang L; Wang R; Jones PP; Chen SR
Biochem J; 2015 Apr; 467(1):177-90. PubMed ID: 25605235
[TBL] [Abstract][Full Text] [Related]
27. Dynamic alterations in myoplasmic Ca2+ in malignant hyperthermia and central core disease.
Lyfenko AD; Goonasekera SA; Dirksen RT
Biochem Biophys Res Commun; 2004 Oct; 322(4):1256-66. PubMed ID: 15336973
[TBL] [Abstract][Full Text] [Related]
28. Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.
Jones PP; Jiang D; Bolstad J; Hunt DJ; Zhang L; Demaurex N; Chen SR
Biochem J; 2008 May; 412(1):171-8. PubMed ID: 18092949
[TBL] [Abstract][Full Text] [Related]
29. Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels.
Priori SG; Napolitano C
J Clin Invest; 2005 Aug; 115(8):2033-8. PubMed ID: 16075044
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop.
Amador FJ; Liu S; Ishiyama N; Plevin MJ; Wilson A; MacLennan DH; Ikura M
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11040-4. PubMed ID: 19541610
[TBL] [Abstract][Full Text] [Related]
31. Ryanodine receptor channelopathies.
Benkusky NA; Farrell EF; Valdivia HH
Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
[TBL] [Abstract][Full Text] [Related]
32. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
[TBL] [Abstract][Full Text] [Related]
34. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1).
Haraki T; Yasuda T; Mukaida K; Migita T; Hamada H; Kawamoto M
Anesth Analg; 2011 Dec; 113(6):1461-7. PubMed ID: 21926372
[TBL] [Abstract][Full Text] [Related]
35. Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms.
Lyfenko AD; Ducreux S; Wang Y; Xu L; Zorzato F; Ferreiro A; Meissner G; Treves S; Dirksen RT
Hum Mutat; 2007 Jan; 28(1):61-8. PubMed ID: 16958053
[TBL] [Abstract][Full Text] [Related]
36. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
[TBL] [Abstract][Full Text] [Related]
37. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model.
Kobayashi S; Yano M; Uchinoumi H; Suetomi T; Susa T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Yamamoto T; Matsuzaki M
Circ J; 2010 Nov; 74(12):2579-84. PubMed ID: 20944434
[TBL] [Abstract][Full Text] [Related]
38. Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity.
Zhao F; Li P; Chen SR; Louis CF; Fruen BR
J Biol Chem; 2001 Apr; 276(17):13810-6. PubMed ID: 11278295
[TBL] [Abstract][Full Text] [Related]
39. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis.
Tilgen N; Zorzato F; Halliger-Keller B; Muntoni F; Sewry C; Palmucci LM; Schneider C; Hauser E; Lehmann-Horn F; Müller CR; Treves S
Hum Mol Genet; 2001 Dec; 10(25):2879-87. PubMed ID: 11741831
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.
Iyer KA; Hu Y; Klose T; Murayama T; Samsó M
Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2122140119. PubMed ID: 35867837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
